Share Print

Siteman Receives American College of Surgeons' Highest Approval

Jason Merrill



Nov. 24, 2008 – The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine has received the highest recognition from American College of Surgeons' Commission on Cancer: a three-year approval with commendation.

The Commission on Cancer (CoC) Approvals Program reviews cancer programs and their performance compared to standards set by the CoC.  A three-year approval with commendation is the CoC’s highest rating and is only awarded when a cancer program complies with all standards and receives commendation ratings for one or more of the eligible standards.

“This is important for our institution,” says Mary Scott, RN, Siteman's director of patient care services.  “This is another review of our program through a nationally recognized certification process, and we’re proud to be recognized.”

Other reviews by national organizations led to Siteman's recognition as one of only 41 National Cancer Institute (NCI) Comprehensive Cancer Centers and one of only 21 members of theNational Comprehensive Cancer Network (NCCN), a group of leading cancer centers dedicated to improving the quality and effectiveness of cancer care.

“The combined recognition from the NCI, NCCN and the Commission on Cancer is another example of why Barnes-Jewish Hospital and our physician colleagues at Washington University School of Medicine are thought of as national leaders in medicine,” says Andy Ziskind, MD, Barnes-Jewish Hospital president.

A site visit by CoC surveyors in August gave specific commendation for Siteman’s outcomes analysis, quality of National Cancer Data Base (NCDB) data submission, clinical trial accrual, and prevention and early detection efforts.